10-K: Globe Life Reports Strong 2025 Growth Amidst Legal Challenges

Globe Life Inc. announced robust financial results for 2025, with net income and total premiums increasing, while navigating ongoing litigation and market shifts.

Summary

• Net income for 2025 reached $1.16 billion, an 8% increase from $1.07 billion in 2024.
• Diluted net income per common share rose 18% to $14.07 in 2025, up from $11.94 in 2024.
• Total premium income increased 5% to $4.9 billion in 2025, driven by a 3% rise in life premium to $3.4 billion and a 9% increase in health premium to $1.5 billion.
• Total net sales grew 13% to $948 million in 2025, with health net sales notably up 36%.
• Book value per share increased 19% to $74.17 in 2025, and 11% excluding accumulated other comprehensive income (AOCI) to $96.16.
• The company repurchased 5.4 million shares of common stock at a total cost of $685 million, with an average price of $126.41 per share in 2025.
• Life insurance underwriting margin increased 12% to $1.5 billion, while health insurance underwriting margin rose 5% to $390 million.
• Excess investment income decreased 16% to $138 million in 2025, primarily due to lower average invested asset growth and reduced yields on certain investments.
• Insurance administrative expenses increased 4% in 2025, mainly due to higher employee and information technology costs.
• The consolidated Company Action Level Risk-Based Capital (RBC) ratio was 316% in 2025, within the target range of 300% to 320%.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting strong financial performance and strategic growth initiatives, though tempered by ongoing significant legal challenges and a decline in excess investment income.

Positives

• Net income and diluted EPS showed strong year-over-year growth, indicating improved profitability.
• Total premium and net sales experienced significant increases, particularly in the health segment, reflecting strong business generation.
• Book value per share saw substantial growth, enhancing shareholder value.
• The company's share repurchase program continued, demonstrating a commitment to returning capital to shareholders.
• Life and health underwriting margins improved, with life margin benefiting from favorable policy obligations and assumption updates.
• The company's RBC ratio remains robust at 316%, well within its target range, indicating strong capitalization and financial stability.
• The Direct to Consumer Division improved its underwriting margin to 33% in 2025 from 29% in 2024, driven by new technology and improved conversion rates without incurring incremental underwriting risk.
• The American Income Life Division increased its average producing agent count by 2% and continues to leverage virtual recruiting, training, and sales activities, which are attractive to new recruits and aid retention.

Negatives

• Excess investment income declined by 16% in 2025, attributed to lower average invested asset growth and reduced yields on short-term investments, commercial mortgage loans, and limited partnerships.
• The health underwriting margin as a percent of premium decreased to 26% in 2025 from 27% in 2024, primarily due to higher claims experience and a shift in premium mix towards United American.
• The United American Division's underwriting margin as a percent of premium declined to 6% in 2025 from 8% in 2024, mainly due to increased claims utilization from Medicare Supplement plans.
• The company faces multiple ongoing legal proceedings, including a securities class action and several shareholder derivative lawsuits, which could require significant resources to defend and potentially result in substantial damages or reputational harm.
• The EEOC determined that certain sales agents were employees, not independent contractors, and alleged discrimination, which could lead to civil action and increased operating costs if agents are reclassified.

Risks

• Reliance on the development and maintenance of various distribution channels, including the ability to recruit, hire, and motivate highly-skilled insurance personnel and producing agents.
• Potential for adverse legal, tax, or financial consequences from actual or alleged misclassification of independent contractors as employees.
• Operational risks associated with the use of third-party vendors, including independent sales agents, which could lower revenues, increase costs, disrupt business, or damage reputation.
• Exposure to market and credit risks in the investment portfolio, including significant downgrades, delinquencies, and defaults, which could result in lower net investment income and increased losses.
• Illiquidity and volatility of alternative investments, such as limited partnerships, potentially affecting investment income and overall portfolio liquidity.
• Negative impact on income from declines in interest rates, or potential realized losses from asset liquidation due to increased interest rates and policyholder surrenders.
• Substantial dependence on available funds from insurance subsidiaries, which are subject to regulatory restrictions on dividend payments.
• Liquidity risks associated with sourcing a concentration of funding from the Federal Home Loan Bank (FHLB), including potential changes in eligible collateral or membership eligibility.
• Adverse capital and credit market conditions affecting the ability to meet liquidity needs, access capital, or increasing the cost of capital.
• Exposure to short selling strategies that could drive down the market price of common stock and result in significant negative publicity, reputational damage, and litigation.
• Variations in actual-to-expected rates of mortality, morbidity, and policyholder behavior, which could materially negatively affect results of operations and financial condition.
• A ratings downgrade or other negative action by a rating agency, potentially limiting dividend capacity from insurance subsidiaries and reducing sales.
• Inability to obtain timely and appropriate premium rate increases for certain supplemental health insurance policies from state regulatory authorities.
• Risk of catastrophic events (e.g., pandemics, natural disasters, terrorism) causing significant claims, disrupting business operations, and impacting workforce.
• Model risk, including financial loss or reputational damage from model errors, limitations, incorrect implementation, or misuse.
• Direct or indirect effects of climate change, potentially increasing weather-related events, impacting mortality/morbidity rates, and affecting investment portfolio prospects.
• Securities class action litigation and shareholder derivative lawsuits, which are inherently uncertain and could have a material adverse effect.
• Extensive federal and state laws regulating the business, with changes in regulation or increased scrutiny potentially having a material adverse impact.
• Changes in accounting standards affecting financial statements, reported profitability, and timing of profit recognition.
• Non-compliance with laws or regulations related to customer and consumer privacy and information security, including third-party vendor failures.
• Failure to maintain effective information systems or manage responsible use of emerging technologies, including artificial intelligence, potentially impairing business operations and financial condition.
• Changes in U.S. federal income tax law increasing tax costs or negatively impacting insurance subsidiaries' capital.
• Damage to the brand and reputation from negative publicity, including short seller reports and allegations of independent agent misconduct.
• Failure to meet expectations relating to corporate responsibility and sustainability standards and practices, leading to adverse regulatory, investor, customer, media, or public scrutiny.

Future Outlook

The company anticipates continued growth in recruiting activity, average producing agent count, and net sales, particularly in the Liberty National Division due to investments in sales technologies and agency middle management. The company expects to continue its share repurchase program as a primary use of excess cash flow, assuming favorable market conditions. Dividends from subsidiaries and excess cash flows are projected to be lower in 2026 due to nonrecurring extraordinary dividends received in late 2024 and 2025. The company is evaluating new accounting standards for income statement expense disaggregation (effective January 1, 2027) and internal-use software capitalization (effective January 1, 2028).

Management Comments

• "Overall, the Company continues to see positive signs in its core operations, including sales and premium growth, and continues to achieve an operating ROE (excluding accumulated other comprehensive income) generally in the mid-teens."
• "We believe this market [lower-middle to middle-income] is underserved, has significant growth potential, and provides us with a distinct competitive advantage."
• "We find this flexibility [virtual recruiting, training, and sales] to be attractive to new recruits as well as a driver of retention in our agency force."
• "This Division [Direct to Consumer] has been focused on improving profitability and improving underwriting margin."
• "Expansion of this Division's presence in larger geographic cities with less penetrated areas will help create long-term sustainable agency growth."
• "While the Company continues to emphasize life insurance sales relative to health, due to life's long-term profitability and its greater contribution to excess investment income, the health business provides a significant contribution to return on equity as it does not require a substantial amount of up-front capital."
• "Our allocation to BBB rated bonds has decreased over the past few years as we have found better risk-adjusted, capital-adjusted value in higher-rated bonds."
• "We will determine the best use of excess cash after ensuring that targeted capital levels are maintained in our insurance subsidiaries. If market conditions are favorable, we currently expect that share repurchases will continue to be a primary use of those funds."
• "Management believes it is unlikely the Company will have to make any material payments under this agreement due to default."
• "Management concludes that adequate provision has been made in the consolidated financial statements for any potential assessments that may result from current or future tax examinations and other tax-related matters for all open years."
• "Management does not believe that it is reasonably possible that such litigation will have a material adverse effect on Globe Life Inc.'s financial condition, future operating results or liquidity."
• "Globe Life Inc. plans to vigorously defend against the lawsuit."
• "As a result, Globe Life Inc. intends to remove disclosures related to this matter from future filings unless there are any material updates."

Industry Context

StockSavvy.ai notes that Globe Life Inc. operates in the lower-middle to middle-income insurance market, which it identifies as underserved with significant growth potential. The company's ability to operate at lower policy acquisition and administrative expense levels than peers allows for competitive rates and higher underwriting margins. The health insurance segment experienced increased demand for Medicare Supplement plans, indicating a consumer shift away from Medicare Advantage plans, which is a notable trend in the broader health insurance industry.

Comparison to Industry Standards

• The company's consolidated Company Action Level RBC ratio of 316% is within its targeted range of 300% to 320%, which management considers more than adequate and sufficient to support its current ratings, aligning with strong industry capitalization benchmarks.
• Major insurance subsidiaries hold financial strength ratings of AAfrom Standard & Poor's and A (Excellent) from A.M. Best, indicating a very strong capacity to meet contractual obligations, comparable to highly-rated industry peers.
• The weighted-average composite quality rating of the fixed-maturity portfolio is A-, consistent with the prior year. While the 42% allocation to BBB-rated bonds is noted as 'high relative to our peers,' it is at its lowest level since 2003, suggesting a strategic shift towards higher-rated assets for better risk-adjusted returns.

Corporate Governance

Legal Proceedings

• A putative securities class action was filed on April 30, 2024, alleging materially false or misleading disclosures about financial performance and public statements from May 8, 2019, through April 10, 2024. The motion to dismiss was denied on September 29, 2025, and the company plans to vigorously defend against it.
• Multiple consolidated shareholder derivative lawsuits were filed in November 2024 and November 2025, alleging breach of fiduciary duty by executives and directors for causing or permitting misleading statements and, in some cases, insider trading and wasting corporate assets. These actions are currently stayed pending the resolution of the securities class action.
• The Equal Employment Opportunity Commission (EEOC) notified the company on September 26, 2024, of a reasonable cause determination that certain sales agents were misclassified as independent contractors and were discriminated against based on sex and race. The conciliation process concluded without resolution, and the EEOC may file a lawsuit. The company intends to remove disclosures on this matter from future filings unless material updates occur.

Related Party Transactions

• U.S. insurance subsidiaries entered into an affiliated 100% quota share coinsurance agreement with Globe Life Re Ltd., a Bermuda-domiciled reinsurer, effective December 1, 2025. This intercompany agreement eliminates in consolidation for U.S. GAAP financial statements.

Stakeholder Impact

• Shareholders: Positive financial results, increased book value per share, and ongoing share repurchases are beneficial. However, significant litigation poses a risk to share price and reputation. Increased quarterly dividends are also positive.
• Employees: Higher employee costs contributed to increased administrative expenses, suggesting investment in compensation. Defined benefit pension plans are well-funded, and comprehensive benefits packages are offered. Stock-based compensation plans are in place.
• Customers: The company's focus on lower-middle to middle-income markets and competitive rates due to efficient operations aim to benefit customers. Increased sales in Medicare Supplement plans indicate meeting customer demand.
• Agents: The company is focused on recruiting, training, and retaining agents, with increased agent counts in exclusive agencies. However, allegations of agent misclassification by the EEOC could impact agent relationships and operating models.
• Creditors: Strong RBC ratios and available liquidity from credit facilities and FHLB borrowings indicate the company's ability to meet financial obligations, which is favorable for creditors. The overall quality rating of the investment portfolio (A-) also supports creditworthiness.

Next Steps

• Continue share repurchases, if market conditions are favorable, as a primary use of excess cash flow.
• Evaluate and implement new accounting standards for income statement expense disaggregation (effective January 1, 2027) and internal-use software capitalization (effective January 1, 2028).
• Vigorously defend against the putative securities class action and shareholder derivative lawsuits.
• Monitor and potentially remove disclosures related to the EEOC matter if no material updates occur.
• Continue to focus on growing and strengthening the agency force, particularly in the American Income Life Division, through financial incentives, training, and technology investments.
• Execute the long-term plan to grow the Liberty National Division through expansion into more densely populated areas and continued improvement in worksite business development.
• Adjust premium rates for Medicare Supplement business based on annual review of utilization and claim cost trends, with new rates becoming effective in the following year on new business.

Key Dates

Recommendation

Globe Life Inc. demonstrates strong operational performance with significant increases in net income, premiums, and sales, alongside a healthy capital position. The continued share repurchase program and dividend increases are positive for shareholders. However, the ongoing and significant legal challenges, including a securities class action and multiple derivative lawsuits, introduce considerable uncertainty and potential financial and reputational risks. The decline in excess investment income is also a point of concern. While the core business is performing well, the unresolved litigation warrants a cautious approach, suggesting that investors should hold their positions until there is greater clarity on the legal outcomes.

Keywords

Life Insurance, Health Insurance, SEC Filing, 10-K, Financial Results, Insurance Underwriting, Investment Income, Share Repurchase, Risk-Based Capital, Corporate Governance, Litigation, Regulatory Compliance, Stock Options, Restricted Stock Units, Medicare Supplement, Direct to Consumer, Agency Distribution, Financial Strength Ratings, Delaware, Texas, Bermuda